Nr. 1, 2008 - Romanian Journal of Cardiology

Ghid de diagnostic şi tratament al sindroamelor coronariene acute
fără supradenivelare de segment ST
place ment: rationale and design of the TARGET study. Am Heart J
2000;140:722-726.
407. Jubelirer SJ, Koenig BA, Bates MC. Acute profound thrombocytopenia
following C7E3 Fab (Abciximab) therapy: case reports, review of the
lit erature and implications for therapy. Am J Hematol 1999;61:205-
208.
408. Merlini PA, Rossi M, Menozzi A, Buratti S, Brennan DM, Moliterno
DJ,Topol EJ, Ardissino D. Thrombocytopenia caused by abciximab
or tirofi ban and its association with clinical outcome in patients
undergoing cor onary stenting. Circulation 2004;109:2203-2206.
409. Bennett SK, Redberg RF. Acute coronary syndromes in women: is
treat ment different Should it be Curr Cardiol Rep 2004;6:243-252.
410. Klein L, Gheorghiade M. Management of the patient with diabetes
mellitus and myocardial infarction: clinical trials update. Am J Med
2004;116(Suppl. 5A):47S-63S.
411. Patel MR, Roe MT. Pharmacological treatment of elderly patients with
acute coronary syndromes without persistent ST segment elevation.
Drugs Aging 2002; 19:633-646.
412. SarnakMJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm
LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P,
Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor
for devel opment of cardiovascular disease: a statement from the
Ameri can Heart Association Councils on Kidney in Cardiovascular
Disea se, High Blood Pressure Research, Clinical Cardiology, and Epide
miology and Preven tion. Circulation 2003;108:2154-2169.
413. Kochanek KD, Smith BL. Deaths: preliminary data for 2002. Natl
Vital Stat Rep 2004;52:1-47.
414. Behar S, Battler A, Porath A, Leor J, Grossman E, Hasin Y, Mittelman
M, Feigenberg Z, Rahima-Maoz C, Green M, Caspi A, Rabinowitz B,
Garty M. A prospective national survey of management and clinical
out come of acute myocardial infarction in Israel, 2000. Isr Med Assoc
J 2003;5:249-254.
415. Wienbergen H, Gitt AK, Schiele R, Juenger C, Heer T, Vogel C,
GottwikM, Senges J. Different treatments and outcomes of consecutive
patients with non-ST-elevation myocardial infarction depending on
initial electrocardiographic changes (results of the Acute Coronary
Syn dromes [ACOS] Registry). Am J Cardiol 2004;93:1543-1546.
416. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Represen
tation of elderly persons and women in published randomized
trials of acute coronary syndromes. JAMA 2001;286:708-713.
417. Kandzari DE, Roe MT, Chen AY, Lytle BL, Pollack CV Jr, Harrington
RA, Ohman EM, Gibler WB, Peterson ED. Influence of clinical trial
enrollmenton the quality of care and outcomes for patients with
non-ST-segment elevation acute coronary syndromes. Am Heart J
2005;149:474-481.
418. Alexander KP, Roe MT, Chen AY, Lytle BL, Pollack CV Jr, Foody JM,Boden
WE, Smith SC Jr, Gibler WB, Ohman EM, Peterson ED. Evolution in
cardio vascular care for elderly patients with non-ST-segment elevation
acu te co ronary syndromes: results from the CRUSADE National
Quality Improvement Initiative. J Am Coll Cardiol 2005;46:1479-
1487.
419. Cohen M, Antman EM, Gurfinkel EP, Radley D. Enoxaparin in unstable
angina/non-ST-segment elevation myocardial infarction: treatment
benefits in prespecified subgroups. J Thromb Thrombolysis 2001;
12:199-206.
420. Bach RG, Cannon CP, Weintraub WS, DiBattiste PM, Demopoulos
LA, Anderson HV, DeLucca PT, Mahoney EM, Murphy SA,
Braunwald E. The effect of routine, early invasive management on
outcome for elderly patients with non-ST-segment elevation acute
coronary syndromes. Ann Intern Med 2004; 141:186-195.
421. Hasdai D, Porter A, Rosengren A, Behar S, Boyko V, Battler A. Effect
of gender on outcomes of acute coronary syndromes. Am J Cardiol
2003;91:1466-1469.
422. MacIntyre K, Stewart S, Capewell S, Chalmers JW, Pell JP, Boyd J,
Finlayson A, Redpath A, Gilmour H, McMurray JJ. Gender and survival:
a population-based study of 201,114 men and women following
a first acute myocardial infarction. J Am Coll Cardiol 2001;38:729-
735.
423. Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van
deWerf F, Aylward P, Topol EJ, Califf RM. Sex, clinical presentation,
Revista Română de Cardiologie
Vol. XXIII, Nr. 1, 2008
and outcome in patients with acute coronary syndromes. Global Use
of Strategies to Open Occluded Coronary Arteries in Acute Coronary
Syn dromes IIb Investigators. N Engl J Med 1999;341:226-232.
424. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K,
Diercks DB, Brogan GX Jr, Boden WE, Roe MT, Ohman EM, Gibler
WB, Newby LK. Gender disparities in the diagnosis and treatment
of non-ST-segment elevation acute coronary syndromes: large-scale
obser vations from the CRUSADE (Can Rapid Risk Stratification of Unstable
Angina Patients Suppress Adverse Outcomes With Early Implementation
of the American College of Cardiology/American Heart
Association Guidelines) National Quality Improvement Initiative. J
Am Coll Cardiol 2005;45:832-837.
425. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K,
Diercks DB, Brogan GX Jr, Boden WE, Roe MT, Ohman EM, Gibler
WB, Newby LK; CRUSADE Investigators. Gender disparities in the
diagnosis and treatment of non-ST-segment elevation acute coronary
syndromes:large-scale observations from the CRUSADE (Can Rapid
Risk Stratifica tion of Unstable Angina Patients Suppress Adverse Outcomes
With Early Implementation of the American College of Cardiology/American
Heart Association Guidelines) National Quality Improvement
Initiative. J Am Coll Cardiol 2005;45:832-837.
426. Rosengren A, Wallentin L, Gitt AK, Behar S, Battler A, Hasdai D. Sex,
age, and clinical presentation of acute coronary syndromes. Eur Heart
J 2004;25:663-670.
427. Cho L, Topol EJ, Balog C, Foody JM, Booth JE, Cabot C, Kleiman
NS, Tcheng JE, Califf R, Lincoff AM. Clinical benefit of glycoprotein
IIb/IIIablockade with Abciximab is independent of gender: pooled
analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3
for the Pre vention of Ischemic Complications. Evaluation in Percutaneous
Transluminal Coronary Angioplasty to Improve Long-Term
Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet
IIb/IIIa Inhibitorfor Stent. J Am Coll Cardiol 2000;36:381-386.
428. Newby LK, Ohman EM, Christenson RH, Moliterno DJ, Harrington
RA, White HD, Armstrong PW, Van De Werf F, Pfisterer M, Hasselblad
V, Califf RM, Topol EJ. Benefit of glycoprotein IIb/IIIa inhibition in patients
with acute coronary syndromes and troponin t-positive sta tus:
the paragon-B troponin Tsubstudy. Circulation 2001;103:2891-2896.
429. Roe MT, Harrington RA, Prosper DM, Pieper KS, Bhatt DL, Lincoff
AM, Simoons ML, Akkerhuis M, Ohman EM, Kitt MM, Vahanian A,
Ruzyllo W, Karsch K, Califf RM, Topol EJ. Clinical and therapeutic
profile of patients presenting with acute coronary syndromes who do
not have significant coronary artery disease. The Platelet Glycoprotein
IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin
The rapy (PURSUIT) Trial nvestigators. Circulation 2000;102:1101-
1106.
430. Bavry AA, Kumbhani DJ, Quiroz R, Ramchandani SR, Kenchaiah S,
Antman EM. Invasive therapy along with glycoprotein IIb/IIIa inhibitors
and intracoronary stents improves survival in non-ST-segment
elevation acute coronary syndromes: a meta-analysis and review of
the literature. Am J Cardiol 2004;93:830-835.
431. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain
DA, Shaw TR, Wheatley DJ, Pocock SJ. Interventional versus con servative
treatment for patients with unstable angina or non-ST-elevation
myo cardial infarction: the British Heart Foundation RITA 3
rando mised trial. Randomized Intervention Trial of unstable Angina.
Lancet 2002;360:743-751.
432. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E.
Out come at 1 year after an invasive compared with a non-invasive
stra t egy in unstable coronary-artery disease: the FRISC II invasive random
ised trial. FRISC II Investigators. Fast Revascularisation during
Instability in Coronary artery disease. Lancet 2000;356:9-16.
433. Glaser R, Herrmann HC, Murphy SA, Demopoulos LA, DiBattiste
PM, Cannon CP, Braunwald E. Benefit of an early invasive mana gement
strat egy in women with acute coronary syndromes. JAMA 2002;
288:3124-3129.
434. Mueller C, Neumann FJ, Roskamm H, Buser P, Hodgson JM,
Perruchoud AP, Buettner HJ. Women do have an improved long-term
outcome after non-ST-elevation acute coronary syndromes treat ed
very early and predominantly with percutaneous coronary inter ven-